Skip to main content
Caplight Logo









Aditum Bio

Aditum Bio

Oakland, Californiaaditumbio.com

Overview

Aditum Bio is a venture capital firm that focuses on acquiring and developing biotechnology assets. The firm's model involves in-licensing promising drug candidates and creating new companies to advance them through Phase II clinical trials.

Year Founded

2019

Portfolio Companies

5

Investments

Aditum Bio investments
CompanyDateStageLead
Oblenio BioJun 2026Series BCo-investor
Kalexo BioSep 2025Corporate FundingLead
Oblenio BioNov 2024Series ALead
Motric BioNov 2021SeedLead
Via Nova TherapeuticsSep 2021Series ALead

Key People

Joe Jimenez

Co-Founder and Managing Director

Josh Gertsman

Partner

Praveena Kandula

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersOakland, California
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?